AdvaMed’s role in India
AdvaMed and its member companies in India have made immense contributions to spreading awareness of the social and economic value of medical devices. They have worked hard to explain the difference between medical devices and pharmaceuticals to all stakeholders. As a consequence, various sections of the Government now appreciate this distinction and, in fact, the Ministry of Commerce & Industry has acknowledged medical devices as one of the five sectors with promising investment potential for domestic as well as export markets.
AdvaMed members in India are actively engaged in skill development with Indian surgeons, physicians, nurses, technicians and other paramedical staff. Members provide advanced levels of education with a focus on the refinement of skills and knowledge through real-time problem solving activities, with emphasis on advanced theory and practice of various branches of medicine. This skill development goes a long way toward reducing expensive errors and maximizing efficiencies in healthcare delivery.
Innovative solutions by AdvaMed members in product development, as well as those in the supply chain, service, delivery and reimbursement mechanisms, have helped make healthcare more affordable and accessible for Indian patients.
Addressing India's disease burden
The World Health Organization, non-communicable diseases (NCD) Country Profiles, 2011 states that more than 53% of total deaths every year in India are due to NCDs and by 2020, over 60 million Indians will succumb to them. With over 62 million diabetics, India is fast becoming the diabetes capital of the world. One of every three adults here has high blood pressure. Hypertension kills nine million people every year. India’s share of the global disease burden – 20 percent with 18 percent of the population – is amongst the worlds most skewed and highest. The share of non-communicable diseases (NCD) in India, such as heart disease, diabetes, osteoarthritis and cancer, diagnosis, treatment and prevention of these is demanding attention like never before.
Medical devices have been playing a tremendous role in mitigating India’s disease burden. While coronary stents have cut the number of patients dying from heart attacks in this country by half, implantable cardiac defibrillators have increased the chances of surviving a sudden cardiac arrest from five per cent to 98 per cent. Diabetics can now use glucose monitoring technologies to escape hypoglycemia, blindness and peripheral nerve damage, and patients in general can spend less time in hospital owing to the minimally invasive technologies used to conduct heart, spine, metabolic and neuro-surgeries. In this context, medical devices have an increasingly critical role to play in helping diagnose and manage NCDs.